怀孕期间母亲感染与婴儿急性淋巴细胞白血病风险之间的关联:系统性审查和元分析
Xi Chen1, Shiping Wang1, Weixia Yu2
1Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Pediatric blood & cancer
|March 16, 2026
概括
怀孕期间的孕妇感染,特别是流感,与儿童急性淋巴细胞白血病 (ALL) 的更高风险有关. 预防产前感染的及时管理对于预防至关重要.
科学领域:
- 流行病学 流行病学
- 儿科瘤学 儿科瘤学
- 传染性疾病 传染性疾病
背景情况:
- 怀孕期间母亲感染是影响儿童癌症风险的潜在环境因素.
- 急性淋巴细胞白血病 (ALL) 是最常见的儿童癌症,其病因是多因素的.
研究的目的:
- 系统地评估怀孕期间母亲感染与儿童ALL风险之间的关联.
- 进行调整和病原体特定数据的元分析,以澄清这种关系.
主要方法:
- 在主要数据库 (PubMed,科学网,Embase,柯克伦图书馆) 进行系统的文献搜索.
- 使用Joanna Briggs Institute (JBI) 检查清单进行数据提取和质量评估.
- 聚合几率比率 (ORs) 为各种感染类型计算,使用灵敏度分析和GRADE方法来确定证据.
主要成果:
- 对于任何母体感染的整合调整后OR为1.18 (95% CI:1.03-1.35)).
- 流感显示出最强的关联 (OR 1.90;95% CI:1.27-2.83).
- 爱斯坦-巴尔病毒和呼吸道感染显示出边缘显著性;尿生殖系统感染可能是人造的.
结论:
- 孕产妇感染,特别是流感,与儿童ALL风险增加有关.
- 在临床上,预防流感和及时管理产前感染是非常重要的.
- 可能需要进一步的研究来澄清边界关联和混因素.
更多相关视频
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
4.4K
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
2.4K
相关概念视频
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
